News

A research team has performed the first-ever genome-wide association study of Latino Parkinson’s disease (PD) patients, marking an important step towards more inclusive PD genetic research.

Cell-free DNA shed into the blood was discovered in the late 1940s. Researchers now believe that studying modifications to this type of DNA may lead to a better understanding of how to assess treatment approaches for cancer and other diseases.

Genomic studies have produced advances in how to calculate and reduce heart-disease risk, however, the benefits don’t necessarily apply to people from historically marginalized racial and ethnic groups and Indigenous populations. Efforts must be made to eliminate barriers to increase their participation in genomic research.

A study of 175 patients with poorly controlled type 2 diabetes found that continuous glucose monitoring, compared to blood glucose meter monitoring significantly decreased their hemoglobin A1C over eight months.

Scientists have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia. The activity of the protein, which is found in both the brain and blood, affects neural connections in human brains and is uniquely imbalanced in people diagnosed with the condition.

A test being developed in Queensland could help to reduce the high mortality rate from ovarian cancer by dramatically improving the accuracy of early detection.

Researchers have developed two tests that can detect the presence of glioma, a type of brain tumor, in patient urine or blood plasma.

Researchers have constructed a portable, thumb-sized device that can diagnose bad breath by detecting the culprit, hydrogen sulfide.

Alzheimer's disease and other forms of neurodegeneration can currently only be confirmed by autopsy. Researchers say identification may be possible using a combination of biomarkers from the cerebrospinal fluid of living patients.

Markers in our blood could help identify individuals who have been infected by SARS-CoV-2 several months after infection even if the individual had mild symptoms or showed no symptoms at all.